Circulation Research

• 

  Publication Venue For

  • A20 in Myeloid Cells Protects Against Hypertension by Inhibiting Dendritic Cell-Mediated T-Cell Activation..  125:1055-1066. 2019
  • ATTRACT..  125:262-264. 2019
  • ApoB..  124:1425-1427. 2019
  • Tumor Suppressors RB1 and CDKN2a Cooperatively Regulate Cell-Cycle Progression and Differentiation During Cardiomyocyte Development and Repair..  124:1184-1197. 2019
  • Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells..  123:1143-1151. 2018
  • Beet the Best?.  123:654-659. 2018
  • G-Protein-Coupled Receptors in Heart Disease..  123:716-735. 2018
  • Established and Emerging Roles of Biomarkers in Heart Failure..  123:614-629. 2018
  • A Path Forward for Regenerative Medicine..  123:495-505. 2018
  • Cross Talk Between S-Nitrosylation and Phosphorylation Involving Kinases and Nitrosylases..  122:1485-1487. 2018
  • Career Development of Young Physician-Scientists in the Cardiovascular Sciences: Perspective and Advice From the Early Career Committee of the Cardiopulmonary, Critical Care, and Resuscitation Council of the American Heart Association..  122:1330-1333. 2018
  • Cardiovascular Metabolomics..  122:1238-1258. 2018
  • Approaching Regulatory Approval of Cardiovascular Regenerative Therapy..  122:552-554. 2018
  • The (Translational) Road Less Traveled..  122:207-209. 2018
  • MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury..  121:930-940. 2017
  • Calcium Signaling and Cardiac Arrhythmias..  120:1969-1993. 2017
  • Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo..  120:1403-1413. 2017
  • Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial..  120:332-340. 2017
  • Cardiovascular Research and the National Academy of Medicine: Advancing Progress in Science and Medicine: Part 1: Who We Are..  120:20-22. 2017
  • Cardiovascular Research and the National Academy of Medicine: Advancing Progress in Science and Medicine: Part 2: What We Do..  120:23-26. 2017
  • Philanthropy for Science: Is It a Viable Option?.  119:1057-1059. 2016
  • Getting Back to Normal: Can Enhanced Regeneration Maintain Health?.  118:1863-1865. 2016
  • Platelet-Mediated Thrombosis: From Bench to Bedside..  118:1380-1391. 2016
  • Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology..  118:95-107. 2016
  • SNOs Differ: Methodological and Biological Implications..  117:826-829. 2015
  • S-Nitrosylation of Calcium-Handling Proteins in Cardiac Adrenergic Signaling and Hypertrophy..  117:793-803. 2015
  • Harnessing the Power of Integrated Mitochondrial Biology and Physiology: A Special Report on the NHLBI Mitochondria in Heart Diseases Initiative..  117:234-238. 2015
  • Relationship of T2-Weighted MRI Myocardial Hyperintensity and the Ischemic Area-At-Risk..  117:254-265. 2015
  • MicroRNAs and Cardiac Regeneration..  116:1700-1711. 2015
  • Conserved microRNA program as key to mammalian cardiac regeneration: insights from zebrafish..  116:1109-1111. 2015
  • CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease..  116:876-883. 2015
  • MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function..  116:418-424. 2015
  • Victor Dzau: cardiovascular physician scientist takes helm at IOM.  117:13-16. 2015
  • Abi3bp regulates cardiac progenitor cell proliferation and differentiation..  115:1007-1016. 2014
  • Ankyrin-G coordinates intercalated disc signaling platform to regulate cardiac excitability in vivo..  115:929-938. 2014
  • Letter by Makkar et al regarding article, "Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions"..  115:e32. 2014
  • Phosphorylation of Nox1 regulates association with NoxA1 activation domain..  115:911-918. 2014
  • Reperfusion strategies in acute coronary syndromes..  114:1918-1928. 2014
  • Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial..  114:1292-1301. 2014
  • Inhibition of the cardiomyocyte-specific troponin I-interacting kinase limits oxidative stress, injury, and adverse remodeling due to ischemic heart disease..  114:938-940. 2014
  • β-arrestin1-biased β1-adrenergic receptor signaling regulates microRNA processing..  114:833-844. 2014
  • A role for peroxisome proliferator-activated receptor γ coactivator-1 in the control of mitochondrial dynamics during postnatal cardiac growth..  114:626-636. 2014
  • Identifying single S-nitrosothiol sites with cardioprotection..  113:849-851. 2013
  • C3orf58, a novel paracrine protein, stimulates cardiomyocyte cell-cycle progression through the PI3K-AKT-CDK7 pathway..  113:372-380. 2013
  • Fibroblast growth factor homologous factors modulate cardiac calcium channels..  113:381-388. 2013
  • Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts..  113:313-321. 2013
  • Essential and unexpected role of Yin Yang 1 to promote mesodermal cardiac differentiation..  112:900-910. 2013
  • Animal models of heart failure: a scientific statement from the American Heart Association..  111:131-150. 2012
  • Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5..  111:50-55. 2012
  • A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension..  110:1604-1617. 2012
  • MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes..  110:1465-1473. 2012
  • Endocrine nitric oxide bioactivity and hypoxic vasodilation by inhaled nitric oxide..  110:652-654. 2012
  • Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease..  109:923-940. 2011
  • Drosophila, genetic screens, and cardiac function..  109:794-806. 2011
  • Fibroblast growth factor homologous factor 13 regulates Na+ channels and conduction velocity in murine hearts..  109:775-782. 2011
  • Intramyocardial, autologous CD34+ cell therapy for refractory angina..  109:428-436. 2011
  • Introduction to the series on novel aspects of cardiovascular G-protein-coupled receptor signaling..  109:202-204. 2011
  • A method to measure myocardial calcium handling in adult Drosophila..  108:1306-1315. 2011
  • Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling..  108:792-796. 2011
  • Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction..  107:418-428. 2010
  • Erythropoietin activates mitochondrial biogenesis and couples red cell mass to mitochondrial mass in the heart..  106:1722-1730. 2010
  • Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium..  106:1753-1762. 2010
  • Gene deletion screen for cardiomyopathy in adult Drosophila identifies a new notch ligand..  106:1233-1243. 2010
  • S-nitrosylation in cardiovascular signaling..  106:633-646. 2010
  • TRPC1 channels are critical for hypertrophic signaling in the heart..  105:1023-1030. 2009
  • A role of matrix metalloproteinase-8 in atherosclerosis..  105:921-929. 2009
  • Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors..  105:852-859. 2009
  • Dynamical mechanism for subcellular alternans in cardiac myocytes..  105:335-342. 2009
  • NADPH oxidase 4: walking the walk with Poldip2..  105:209-210. 2009
  • Calcineurin finds a new partner in the L-type Ca2+ channel..  105:7-8. 2009
  • Accessory subunit KChIP2 modulates the cardiac L-type calcium current..  104:1382-1389. 2009
  • Angiopoietin-2 confers Atheroprotection in apoE-/- mice by inhibiting LDL oxidation via nitric oxide..  104:1333-1336. 2009
  • Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1..  103:1232-1240. 2008
  • Paracrine mechanisms in adult stem cell signaling and therapy..  103:1204-1219. 2008
  • Nitroglycerin-mediated S-nitrosylation of proteins: a field comes full cycle..  103:557-559. 2008
  • Hypoxic vasodilation by red blood cells: evidence for an s-nitrosothiol-based signal..  103:545-553. 2008
  • Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration..  103:70-79. 2008
  • Negative-feedback loop attenuates hydrostatic lung edema via a cGMP-dependent regulation of transient receptor potential vanilloid 4..  102:966-974. 2008
  • Annexin 2/factor xa-mediated signal transduction..  102:389-391. 2008
  • Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1..  101:948-956. 2007
  • Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3..  101:663-671. 2007
  • Cell polarization defects in early heart development..  101:122-124. 2007
  • Seven-transmembrane receptors and ubiquitination..  100:1142-1154. 2007
  • The bone morphogenetic protein antagonist noggin regulates mammalian cardiac morphogenesis..  100:220-228. 2007
  • Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudy..  99:1141-1147. 2006
  • Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury..  99:988-995. 2006
  • APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt Pathway via the phosphoinositol phosphatase SHIP2..  99:829-836. 2006
  • Trafficking of G protein-coupled receptors..  99:570-582. 2006
  • Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function..  99:442-450. 2006
  • Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium..  99:315-322. 2006
  • KCNQ1 assembly and function is blocked by long-QT syndrome mutations that disrupt interaction with calmodulin..  98:1048-1054. 2006
  • GATA4 and the two sides of gene expression reprogramming..  98:715-716. 2006
  • Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy..  98:540-548. 2006
  • COX-2-derived prostacyclin modulates vascular remodeling..  96:1240-1247. 2005
  • Oxygen regulation of tumor perfusion by S-nitrosohemoglobin reveals a pressor activity of nitric oxide..  96:1119-1126. 2005
  • Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway..  95:506-514. 2004
  • IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation..  95:276-283. 2004
  • How do red blood cells dilate blood vessels?.  94:e105. 2004
  • G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning..  94:1133-1141. 2004
  • Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation..  94:601-608. 2004
  • S-nitrosothiols in the blood: roles, amounts, and methods of analysis..  94:414-417. 2004
  • Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases..  92:1322-1329. 2003
  • A magnificent time with the "magnificent seven" transmembrane spanning receptors..  92:342-344. 2003
  • Differential actions of PAR2 and PAR1 in stimulating human endothelial cell exocytosis and permeability: the role of Rho-GTPases..  92:272-278. 2003
  • Regulation of the brain's vascular responses to oxygen..  91:1031-1037. 2002
  • Regulation of G protein-coupled receptor signaling by scaffold proteins..  91:672-680. 2002
  • Transcription factor decoy..  90:1234-1236. 2002
  • Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice..  90:594-601. 2002
  • Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart..  90:297-304. 2002
  • Regression of atherosclerosis in monkeys reduces vascular superoxide levels..  90:277-283. 2002
  • Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice..  89:168-173. 2001
  • Adaptive mechanisms that preserve cardiac function in mice without myoglobin..  88:713-720. 2001
  • Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles..  87:E61-E68. 2000
  • Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i)..  87:705-709. 2000
  • Microvascular integrity and the time course of myocardial sodium accumulation after acute infarction..  87:648-655. 2000
  • Canaries in the coal mine: mitochondrial DNA and vascular injury from reactive oxygen species..  86:915-916. 2000
  • Enhanced cardiac function in transgenic mice expressing a Ca(2+)-stimulated adenylyl cyclase..  86:795-801. 2000
  • Abnormal cardiac Na(+) channel properties and QT heart rate adaptation in neonatal ankyrin(B) knockout mice..  86:441-447. 2000
  • Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells..  85:524-533. 1999